- 24.1k views
Anticoagulants in CVD
The financial burden of thrombotic events in cardiovascular disease is enormous. Anticoagulant medication is advised for the treatment and secondary prevention of acute coronary syndrome as well as the prevention of thrombotic events in numerous cardiovascular disorders, such as stroke in atrial fibrillation. Present-day parenteral anticoagulants consist of fondaparinux, low-molecular-weight heparins (LMWHs), and unfractionated heparin. When admitted to the hospital, patients with acute coronary syndrome are typically given either unfractionated heparin or a low-molecular weight heparin (LMWH). Both treatments are equally effective in lowering the risk of death and myocardial infarction, although LMWHs may be safer and don't need to be monitored for blood clotting. Using fondaparinux reduces mortality from acute coronary syndrome considerably when compared to LMWHs or unfractionated heparin. However, long-term outpatient usage of parenteral medications is inconvenient. The only oral anticoagulants available at this time are vitamin K antagonists. A large unmet need exists for new convenient and well-tolerated oral anticoagulants that do not require routine monitoring.
About the Speaker
Dr. Abhishek Tiwari
Consultant Interventional Cardiologist, Ahalia Hospital, Coimbatore
Dr. Abhishek Tiwari, Consultant Interventional Cardiologist, Ahalia Hospital, Coimbatore
Upcoming Case Discussions
Impact of Endometriosis on Fertility
Endometriosis, a condition where endometrial-like tissue grows outside the uterus, can significantly impact fertility. It causes inflammation, scarring, and adhesions that may distort pelvic anatomy, block fallopian tubes, and impair ovarian function. Endometriosis is also linked to hormonal imbalances and poor egg quality, reducing the chances of conception. Symptoms like chronic pelvic pain and painful intercourse further complicate fertility. Diagnosis often requires laparoscopy, while management includes pain relief, hormonal therapy, and assisted reproductive techniques like IVF. Early intervention with medical or surgical treatment can improve reproductive outcomes, but severe cases may necessitate advanced fertility treatments for conception.
Hyperlipidemia: From Diagnosis to Treatment
Hyperlipidemia is a condition characterized by elevated levels of lipids, such as cholesterol and triglycerides, in the blood, which can increase the risk of cardiovascular diseases. Diagnosis typically involves blood tests measuring lipid profiles, while treatment focuses on lifestyle changes, such as diet and exercise, alongside medications like statins to manage cholesterol levels and reduce cardiovascular risk. Regular monitoring is essential for effective management and prevention of complications.
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Lung Ultrasound in Acute Respiratory Failure
Lung ultrasound has emerged as a vital, non-invasive tool in the rapid assessment of acute respiratory failure. It provides real-time imaging to differentiate conditions like pneumonia, pulmonary edema, pneumothorax, and pleural effusion with high accuracy. Compared to traditional chest X-rays, lung ultrasound offers superior sensitivity, especially in critically ill patients where bedside evaluation is crucial. Its ability to guide immediate clinical decisions improves patient outcomes and reduces unnecessary radiation exposure. With standardized protocols like the BLUE (Bedside Lung Ultrasound in Emergency) protocol, it enhances diagnostic efficiency in emergency and ICU settings.
Gallstone Disease & Cholecystitis: When to Operate?
iGallstone disease and cholecystitis are common conditions requiring careful evaluation to determine the need for surgery. Symptomatic gallstones causing recurrent pain, nausea, or complications like cholecystitis often necessitate cholecystectomy. Acute cholecystitis, characterized by inflammation, fever, and right upper quadrant pain, typically requires early surgical intervention to prevent complications like perforation or sepsis. In high-risk patients, conservative management with antibiotics and drainage may be considered. Elective surgery is recommended for asymptomatic patients with high-risk factors, such as large gallstones or gallbladder polyps, to prevent future complications.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Abhishek Tiwari's Talks on Assimilate
- 12th -Sep-2024, TIME : 5:00PM TO 6:00 PM
- 0
The financial burden of thrombotic events in cardiovascular disease is enormous. Anticoagulant medication is advised for the treatment and secondary prevention of acute coronary syndrome as well as the prevention of thrombotic events in numerous cardiovascular disorders, such as stroke in atrial fibrillation. Present-day parenteral anticoagulants consist of fondaparinux, low-molecular-weight heparins (LMWHs), and unfractionated heparin. When admitted to the hospital, patients with acute coronary syndrome are typically given either unfractionated heparin or a low-molecular weight heparin (LMWH). Both treatments are equally effective in lowering the risk of death and myocardial infarction, although LMWHs may be safer and don't need to be monitored for blood clotting. Using fondaparinux reduces mortality from acute coronary syndrome considerably when compared to LMWHs or unfractionated heparin. However, long-term outpatient usage of parenteral medications is inconvenient. The only oral anticoagulants available at this time are vitamin K antagonists. A large unmet need exists for new convenient and well-tolerated oral anticoagulants that do not require routine monitoring.